Introduction A complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood Heart fails to act as a pump Manifested by cardinal symptoms Dyspnoea & fatigue exercise intolerance Fluid retention pulmonary oedema, splanchnic oedema, peripheral oedema
Neurohormonal mediated cascade *At the cost of increasing myocardial workload, wall tension and myocardial oxygen demand
Counter regulatory response Atrial natriuretic peptides (Atria) B-type natriuretic peptide (Ventricle) C-type natriuretic peptide (Localized in endothelium) Effects: Vasodilation, natriuresis, decreased levels of endothelin, and inhibition of RAAS and SNS Importance: (Assays) Elevated levels portend a worse prognosis Attenuation provides the basis for most chronic therapies proven to delay morbidity and mortality
Assays for BNP in ED use N-t pre-pro-BNP
Classification*
Classification Acute vs Chronic Systolic vs Diastolic dysfunction Right sided vs Left sided High output vs Low output
Systolic vs diastolic Systolic Diastolic Age All ages Frequently elderly Sex Often male Frequently female LV EF Decrease ( <50 ) Normal ( Preserved ) LV cavity size Dilate ( increase intracardiac volume ) Normal ( often with LVH )
Current categorization Heart failure with a reduced ejection fraction ( HFrEF ) [ SYSTOLIC] Heart failure with preserved ejection fraction ( HFpEF ) [DIASTOLIC]
Common causes of heart failure
Diagnosis History Clinical examination Fisk factors Precipitating factor Investigations
History – cardinal symptoms Dyspnoea on exertion Orthopnoea Paroxysmal nocturnal dyspnoea Edema Fatigue
History – other symptoms Cough with expectoration CNS : Altered sensorium, confusion, impairment of memory, headache, insomnia GI : Anorexia, nausea, vomiting, pain abdomen, abdominal fullness GU: Nocturia
Dyspnoea
Differential for dyspnoea Exacerbation of asthma or COPD Pulmonary embolus Pneumonia Acute coronary syndrome Anaphylaxis
Risk factors Male Old ages Hypertension Diabetes mellitus Valvular heart disease obesity
Precipitating factors
General Physical Examination Mild to moderate HF : No distress except when lying flat for more than a few minutes Severe HF: Must sit upright, labored breathing, unable to finish a sentence Cardiac cachexia Cyanosis Edema Jaundice
Chest x-ray (upright) Pulmonary venous congestion Cardiomegaly (80%) or normal (20%) Interstitial edema Most specific for a final diagnosis of acute heart failure but the absence of these does not rule it out
Cardiomegaly CTR = 18/30 (>50%) Upper zone vessel enlargement ( 1 ) – a sign of pulmonary venous hypertension Septal ( Kerley B) lines ( 2 ) – a sign of interstitial oedema – see next picture Airspace shadowing ( 3 ) – due to alveolar oedema – acutely in a peri -hilar (bat's wing) distribution Blunt costophrenic angles ( 4 ) – due to pleural effusions
Electrocardiogram Not useful for diagnosis Early recognition of arrhythmias – atrial fibrillation Signs of ischaemia or injury
Irregularly irregular rhythm. No P waves. Absence of an isoelectric baseline. Variable ventricular rate. QRS complexes usually < 120 ms
Routine Complete blood count to evaluate anaemia Basic metabolic panel Electrolytes Renal status
Cardiac biomarkers It is done when cause of dyspnoea is still unclear after standard evaluation This test will detect ongoing myocyte injury , which may be clinically silent
Bedside ultrasound Determine cause of dyspnoea e.g. tamponade Determine LV function and volume status RWMA Valvular abnormality Focused on 1. Signs of pulmonary congestion 2. Sign of volume overload 3. LV ejection fraction
Signs of pulmonary congestion Sonographic B-lines Dx – >2 B-lines in any sonographic windows along the anterior and posterior chest
Signs of volume overload IVC >2 cm diameter Collapsibility index <50% Indicates raised in central venous pressure
Management in ED
Disposition decision Lack of ED-based-risk stratification tool Mainly based on Physician judgement Physiologic risk assessment Assessments of barrier to successful outpatient High risk physiological marker 1. Renal dysfunction 3. Low serum sodium 2. Low BP 4. Increase natriuretic peptide / cardiac troponin
High risk features admission to ward Patient required invasive monitoring / procedure ICU Lower risk features observation unit (12-24h)